Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimising and Standardising Measurements of Inflammatory Markers in Exhaled Breath (EB) and Exhaled Breath Condensate (EBC)

NCT00983671 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00983671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimising and Standardising Measurements of Inflammatory Markers in Exhaled Breath (EB) and Exhaled Breath Condensate (EBC)
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2010
Completion date
December 31, 2013
Enrollment
255 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic lung disease, cystic fibrosis, pneumonia